;
Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Orexo raises $50.6 million

    Orexo AB (SSE:ORX; OTCQX:ORXOY) raised SEK346.5 million ($50.6 million) through the sale of 2.5 million shares at SEK139 in a private placement. The company sold 1.1 million treasury shares and issued 1.4 million new …

    Published on 8/29/2014
  • FINANCIAL NEWS: Titan proposes to raise up to $12 million

    Titan Pharmaceuticals Inc. (OTCBB:TTNP) proposed to raise up to $12 million through the sale of units in a follow-on underwritten by Roth Capital Partners. Each unit comprises a share and a warrant to purchase a share.…

    Published on 8/29/2014
  • FINANCIAL NEWS: Orexo raising private placement

    Orexo AB (SSE:ORX; OTCQX:ORXOY) is raising an undisclosed amount in a private placement with Swedish and international institutional and strategic investors. Danske Bank is the sole lead manager and bookrunner.Orexo …

    Published on 8/28/2014
  • FINANCIAL NEWS: Bellicum secures $55 million in series C

    Bellicum Pharmaceuticals Inc. (Houston, Texas) secured $55 million in a series C round from 11 new investors, including RA Capital; Perceptive Advisors; Jennison Associates; Sabby Capital; Ridgeback Capital Management; …

    Published on 8/27/2014
  • FINANCIAL NEWS: Capnia amends IPO

    Capnia Inc. (Redwood City, Calif.) amended its IPO on NASDAQ and now plans to raise $11.1 million through the sale of 1.7 million units at $6.50. Each unit comprises a share and a five-year warrant to purchase a share …

    Published on 8/27/2014
  • FINANCIAL NEWS: Dermatology play Dermira files for IPO

    Dermira Inc. (Redwood City, Calif.) filed to raise up to $75 million in an IPO on NASDAQ underwritten by Citigroup; Leerink; Guggenheim Securities; and Needham. Dermira said partner UCB Group (Euronext:UCB) may purchase…

    Published on 8/27/2014
  • FINANCIAL NEWS: Napo's Jaguar Animal Health files for IPO

    The Jaguar Animal Health Inc. subsidiary of Napo Pharmaceuticals Inc. (San Francisco, Calif.) filed to raise up to $70 million in an IPO on NASDAQ underwritten by BMO Capital Markets; Guggenheim Securities; and Roth …

    Published on 8/27/2014
  • FINANCIAL NEWS: Rhythm files for IPO

    Rhythm Pharmaceuticals Inc. (Boston, Mass.) filed to raise up to $86.3 million in an IPO on NASDAQ underwritten by Citigroup; Cowen; Canaccord Genuity; Oppenheimer; and Cantor Fitzgerald. Rhythm expects to begin a Phase…

    Published on 8/27/2014
  • FINANCIAL NEWS: Cancer play Calithera files for IPO

    Calithera Biosciences Inc. (South San Francisco, Calif.) filed to raise up to $80 million in an IPO on NASDAQ underwritten by Citigroup; Leerink Partners; Wells Fargo Securities; and JMP Securities. In February, …

    Published on 8/26/2014
  • FINANCIAL NEWS: Civitas files for IPO

    Civitas Therapeutics Inc. (Chelsea, Mass.) filed to raise up to $86.3 million in an IPO on NASDAQ underwritten by J.P. Morgan; BofA Merrill Lynch; Cowen; and Oppenheimer. Civitas plans to start Phase III testing of CVT-…

    Published on 8/26/2014
  • FINANCIAL NEWS: FortuneRock raises $23.6 million

    FortuneRock Ltd. (Beijing, China) raised RMB145 million ($23.6 million) in a venture round from international investors including Jinhua Pharmaceutical Co. Ltd. FortuneRock will use RMB120 million to spin out a company …

    Published on 8/26/2014
  • FINANCIAL NEWS: NeuroSigma files for IPO

    NeuroSigma Inc. (Los Angeles, Calif.) filed to raise up to $50 million in an IPO on NASDAQ underwritten by Jefferies; BTIG; and Craig-Hallum Capital Group. NeuroSigma markets its Monarch external trigeminal nerve …

    Published on 8/26/2014
  • FINANCIAL NEWS: Aldea closes $24 million B round

    Aldea Pharmaceuticals Inc. (Redwood City, Calif.) closed a $24 million series B round led by new investor RusnanoMedInvest. New investor WuXi PharmaTech Corporate Venture also participated, along with all of Aldea's …

    Published on 8/25/2014
  • FINANCIAL NEWS: Civitas secures $55 million in series C

    Civitas Therapeutics Inc. (Chelsea, Mass.) secured $55 million in a series C round from new investors Adage Capital Management; OrbiMed Advisors; Partner Fund Management; Rock Springs Capital; and Sofinnova Ventures. …

    Published on 8/25/2014
  • FINANCIAL NEWS: Median Technologies raising EUR 20 million

    Median Technologies Inc. (Euronext:ALMDT) plans to raise about EUR 20 million ($26.8 million) through the sale of 2.2 million units at EUR 9 in a private placement with institutional investors. Each unit comprises a …

    Published on 8/25/2014
  • FINANCIAL NEWS: AbbVie secures loans for Shire acquisition

    AbbVie Inc. (NYSE:ABBV) secured L3.2 billion ($5.4 billion) in a term loan and $4 billion in a revolving credit facility to help fund its acquisition of Shire plc (LSE:SHP; NASDAQ:SHPG). AbbVie is buying Shire for about…

    Published on 8/22/2014
  • FINANCIAL NEWS: Bao Hao buying stake in 20/20 GeneSystems

    A U.S. affiliate of China's Bao Hao Investment Management Co. Ltd. will pay an undisclosed amount to acquire an equity stake in diagnostics company 20/20 GeneSystems Inc. (Rockville, Md.). 20/20 GeneSystems markets …

    Published on 8/22/2014
  • FINANCIAL NEWS: Ribomic planning Tokyo IPO

    Ribomic Inc. (Tokyo, Japan) is planning to raise Y2.7 billion ($26.3 million) through the sale of 1.2 million shares on the Tokyo Stock Exchange's Mothers in an IPO underwritten by Daiwa Securities and six other …

    Published on 8/22/2014
  • FINANCIAL NEWS: WaferGen raises $20M, moves to NASDAQ

    WaferGen Bio-systems Inc. (NASDAQ:WGBS) raised $20 million in a follow-on and moved its listing to NASDAQ from the over-the-counter market. Ladenburg Thalmann; National Securities; and Brean Capital were underwriters. …

    Published on 8/22/2014
  • FINANCIAL NEWS: NeuroDerm raises $16 million

    NeuroDerm Ltd. (Rehovot, Israel) raised $16 million in an undisclosed venture round from existing and new investors including Elias Group. A low-dose version of NeuroDerm's lead program ND0612L is in an Israeli Phase …

    Published on 8/21/2014
  • FINANCIAL NEWS: GeneReach raises $5.5 million in Taiwanese IPO

    Molecular diagnostics play GeneReach Biotechnology Corp. (GreTai:4171) raised NT$166 million ($5.5 million) last week through the sale of 4 million shares at about NT$41.09 in an IPO on the GreTai Securities Market. …

    Published on 8/20/2014
  • FINANCIAL NEWS: Shanghai, Hong Kong exchanges to establish trading link

    The Shanghai and Hong Kong stock exchanges are conducting final tests and rehearsals ahead of the initial launch of a trading link between the two exchanges. The pilot program -- dubbed Shanghai-Hong Kong Stock Connect…

    Published on 8/20/2014
  • FINANCIAL NEWS: Dermatology play Dermira raises $51 million in series C

    Dermira Inc. (Redwood City, Calif.) raised $51 million in a series C round and announced a number of management changes and board appointments. The C round came from existing investors Bay City Capital; New Enterprise …

    Published on 8/19/2014
  • FINANCIAL NEWS: HealthQuest raises $110M for initial fund

    HealthQuest Capital raised $110 million for its debut fund, more than doubling its initial $50 million target. The fund will invest in the medical device, diagnostic, patient care product, consumer health/OTC and …

    Published on 8/19/2014
  • FINANCIAL NEWS: Chugai rises on Roche rumors

    Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) jumped Y510 (15%) to Y3,825 on Monday on reports that parent company Roche (SIX:ROG; OTCQX:RHHBY) is looking to buy the 40% of Chugai it does not already own. The Japanese …

    Published on 8/18/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993